Alba Sanz Sanjuan, Dr. Danielle Clancy, and Prof. Savvas Savvides
Alba Sanz Sanjuan, Dr. Danielle Clancy, and Prof. Savvas Savvides

Scientists reveal how developing immune cells fine-tune their signals

Ghent, 27 May 2026 - Researchers at VIB, Ghent University, and VUB have uncovered how two proteins essential for immune cell development work together at the molecular level. The findings provide important insights into a critical mechanism that mediates the integration of molecular signals received from immunological threats. Their work appears in Nature Communications.

Solving a long-standing mystery in T cell biology

T cells undergo a strict selection process in the thymus before they become fully functional. This ensures that healthy T cells can recognize immunological threats while avoiding attacks against the body’s own tissues. Dysregulation of this process can contribute to autoimmune diseases or immune deficiencies.

For nearly two decades, scientists have known that a protein called Themis is essential for this developmental checkpoint. However, exactly how Themis worked at the molecular level remained unclear.

“Themis has always been something of an enigma,” says Dr. Danielle Clancy (VIB-UGent Center for Inflammation Research), first author of the study. “We knew it played a critical role in T cell development, but we lacked a structural understanding of how it interacts with signaling partners to carry out its function.”

The new study reveals, for the first time, the three-dimensional structure of Themis bound to Grb2, a multifunctional protein involved in numerous signaling pathways inside cells.

A dynamic signaling hub

Using cryo-electron microscopy, the researchers discovered that Themis wraps around Grb2 in an unexpectedly intricate way. At the same time, part of Grb2 remains flexible, allowing the complex to recruit other signaling proteins when T cells are activated.

Illustration of how the Themis-Grb2 complex affects T cell development.
Illustration of how the Themis-Grb2 complex affects T cell development.
“What surprised us most was how extensively Themis embraces Grb2,” explains Prof. Savvas Savvides (VIB-UGent), senior author of the study.
“The interaction is much more sophisticated than anyone anticipated, involving multiple cooperative contact points that stabilize the resulting constitutive complex”, adds Clancy.

The team also showed that disrupting this interaction interferes with important signaling events, confirming that the Themis-Grb2 complex is essential for proper T cell development. ​

 

“Our work provides a structural blueprint for a key signaling hub in the immune system,” say Clancy and ​ Savvides. “These insights will help us better understand how immune cells develop and may eventually support new approaches for treating immune-related diseases.”

Publication

Structural and mechanistic insights into the constitutive Themis-Grb2 complex in T cell signaling. Clancy, et al. Nature Communications, 2026. DOI: 10.1038/s41467-026-73359-8

Funding

This work was supported by Research Foundation Flanders – FWO and VIB.


Kristof Windels

Kristof Windels

Media Relations Manager, VIB
Gunnar De Winter

Gunnar De Winter

Science Communication Manager, VIB

 

Share

Latest stories

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Leuven, 4 November 2026 – Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells that help the human brain grow. This disruption explains how these mutations cause microcephaly, a condition characterized by an abnormally small brain and head, often accompanied by intellectual disability. The discovery, published in Developmental Cell, also sheds light on how differences in brain development can make humans more susceptible to certain genetic conditions than other mammals.

press.vib.be

How blocking immune cell signals could make brain tumors easier to remove

How blocking immune cell signals could make brain tumors easier to remove

Leuven, Belgium, 27 October 2026 – In a new study published in Cancer Cell, researchers at VIB-KU Leuven reduced the spread of glioblastoma by interrupting specific interactions between the brain’s immune cells and tumor cells. The discovery points to a possible new therapeutic strategy, in which blocking communication between immune and cancer cells makes tumors more contained and easier to remove.

press.vib.be

Human stem-cell model reveals a shared origin for tissue-resident macrophages

Human stem-cell model reveals a shared origin for tissue-resident macrophages

VIB researchers have developed a new human stem-cell-based model that recreates an early stage of immune-cell development and shows how a single progenitor population can give rise to specialized macrophages across different organs. The model provides a platform to study how these processes change in disease, and how they might eventually be harnessed therapeutically.

press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be